Post by Syntegon

GMP-PharmaCongress & GMP-PharmaTechnica cemented a simple reality: Annex 1 is in force, but turning guidance into practice remains challenging.​ Conversations with manufacturers, regulators and partners highlighted persistent compliance gaps and a preference for pragmatic, scalable solutions over theory. ​Our position in the industry was reinforced, offering integrated technology, regulatory know‑how and hands‑on support to help teams translate Annex 1 into validated, reliable production.​ The path forward is collaborative: closer regulator alignment, responsible use of smart tools, and co‑creation to scale solutions that protect biologics and patients.​ Read more: https://lnkd.in/dV-T5vK8 #COCREATE #COSUCCEED #Syntegon #LifecyclePartner